Propanc Biopharma, Inc. (PPCB)

NASDAQ

$0.65

$+0.01

(+1.09%)

Pre-Market

Propanc Biopharma, Inc. (PPCB) Live Price Chart

Last updated: ⁦2026-09-18 13:26:40⁩. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.

Summary

Propanc Biopharma, Inc. (PPCB) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $0.65, with a market capitalisation of $1.45M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $0.63 to $57.00. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$1.45M
Open	$0.64
Day's High	$67,500,000.00
Day's Low	$0.63
Previous Close	$0.63
Volume	8.46K
Average Volume	2.73M
P/E Ratio	--
52-Week High	$57.00
52-Week Low	$0.63
Dividend Yield	--
Earnings Date	--

Propanc Biopharma, Inc. (PPCB) Pre-Market Stock Price

Propanc Biopharma, Inc. (PPCB) is trading at $0.65 in pre-market trading as of 2026-09-18 13:25:00, up 3.17% ($0.02) from the previous close of $0.63

Pre-market trading shows how investors are pricing PPCB before the regular session opens. The current pre-market price is above the previous close, indicating positive early trading sentiment.

Propanc Biopharma, Inc. (PPCB) 7-Day Stock Price Change

Over the past seven days, Propanc Biopharma, Inc. (PPCB) moved from $0.99 to $0.65, representing a decline of 34.34% ($0.34).

The stock traded between $0.63 and $1.03 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.

The average daily volume was 382.38 thousand shares, down versus the previous seven-day period, indicating lower trading activity.

PPCB 52-Week Price Position

Position in Range: 0.0%

52W Low$0.63

52W High$57.00

PPCB is currently trading at $0.65, placing it 0.0% of the way from its 52-week low of $0.63 to its 52-week high of $57.00. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Propanc Biopharma, Inc. (PPCB)?

Propanc Biopharma Inc is a development-stage healthcare company. It focuses on developing new cancer treatments for patients suffering from pancreatic, ovarian, and colorectal cancer. The company develops a rational, composite formulation of the anti-cancer compound, which together exert a number of effects designed to control or prevent tumors from recurring and spreading through the body. Its product, PRP, is a variation upon its novel formulation and involves proenzymes, the inactive precursors of enzymes.

Propanc Biopharma, Inc. Information

Industry	PHARMACEUTICAL PREPARATIONS
Employees	2
Exchange	NASDAQ
Company Website	https://www.propanc.com

How to Buy Propanc Biopharma, Inc. (PPCB) Stock on MEXC

Eligible investors can buy real shares of Propanc Biopharma, Inc. (PPCB) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licenced broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for PPCB and Place Your Order

Open the RealStocks trading page and search for PPCB. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Propanc Biopharma, Inc. (PPCB) stock price today?

Propanc Biopharma, Inc. (PPCB) is currently trading at $ 0.65, up 3.17% ($0.02) from the previous close of $ 0.63. Intraday prices update in real time during regular trading hours.

2.Is PPCB stock going up or down today?

As of 2026-09-18 13:25:00, PPCB is trading at $ 0.65, up 3.17% ($0.02) from its previous close of $ 0.63. The stock has traded between $ 0.63 and $ 67,500,000.00 during today’s regular session. Past price movements do not guarantee future results.

3.What is PPCB pre-market price?

As of 2026-09-18 13:25:00, PPCB is trading at $ 0.65 in pre-market trading, up 3.17% ($0.02) from the previous close of $ 0.63. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is PPCB after-hours price?

As of 2026-09-18 13:25:00, PPCB is trading at $ 0.64 in after-hours trading, up 1.59% ($0.01) from the regular-session close of $ 0.63. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is PPCB stock trading now?

PPCB trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does PPCB sit relative to its 52-week high and low?

Over the past 52 weeks, PPCB has traded between a low of $ 0.63 and a high of $ 57.00. At $ 0.65, the stock is positioned 0.0% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Propanc Biopharma, Inc. in?

Propanc Biopharma, Inc. (PPCB) operates in the PHARMACEUTICAL PREPARATIONS sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Propanc Biopharma, Inc.'s market capitalisation and where is it listed?

Propanc Biopharma, Inc. is listed on the NASDAQ exchange with a market capitalisation of $ 1.45M. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is PPCB valued in terms of P/E ratio and EPS?

PPCB trades at a P/E ratio of --, based on trailing-twelve-month EPS of $ -8.47. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Propanc Biopharma, Inc. pay a dividend?

Propanc Biopharma, Inc. pays an indicated annual cash dividend of $ 0.00 per share, with a current dividend yield of 0.00% based on the latest share price. Dividend policies are subject to change at the board's discretion.